Felix Y. Feng

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

5.2Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.034

Top 5%

4.7DataRank

Top 5%141 citations

E.S. Paulson, Brian J. Davis, Daniel E. Spratt, Todd M. Morgan, David P. Dearnaley +20 more

Papers

Driven by 105 papers — median percentile 78. Top paper: “NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer”.

NRG Oncology Updated International Consensus Atlas on Pelvic Lymph Node Volumes for Intact and Postoperative Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2020)10.1016/j.ijrobp.2020.08.034

Top 5%

4.7DataRank

Top 5%141 citations

E.S. Paulson, Brian J. Davis, Daniel E. Spratt, Todd M. Morgan, David P. Dearnaley +20 more

Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.12.035

N/A

1.1DataRank · unranked

51 citations

Huei–Chung Huang, Daniel E. Spratt, Elai Davicioni, Howard M. Sandler, William U. Shipley +17 more

Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2

Cancer Research(2022)10.1158/0008-5472.can-21-4335

N/A

0.884DataRank · unranked

28 citations

Huadong Chen, Yagmur U. Doruk, Tess Williamson, Benjamin J. Polacco, Andrew S. McNeal +13 more

Single-cell analysis of human primary prostate cancer reveals the heterogeneity of tumor-associated epithelial cell states

Nature Communications(2022)10.1038/s41467-021-27322-4

N/A

0.846DataRank · unranked

281 citations

H Weinstein, Paul Allegakoen, Marc H. Wadsworth, Jamie Xie, Heiko Yang +10 more

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

Nature Communications(2020)10.1038/s41467-020-19328-1

N/A

0.752DataRank · unranked

149 citations

Anke Augspach, Maria Rosaria De Filippo, Davide Prandi, Phillip Thienger, Matteo Benelli +27 more

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

Annals of Oncology(2021)10.1016/j.annonc.2021.06.003

N/A

0.654DataRank · unranked

77 citations

Hsin-Chieh Huang, V. Wang, Yu‐Hui Chen, Felix Y. Feng, Robert B. Den +11 more

Theranostic Targeting of CUB Domain–Containing Protein 1 (CDCP1) in Multiple Subtypes of Bladder Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-1973

N/A

0.553DataRank · unranked

11 citations

Kai Trepka, Sasank Sakhamuri, Alberto Carretero-González, Jun Zhu, Emily A. Egusa +9 more

Immunogenic priming with 177Lu-PSMA-617 plus pembrolizumab in metastatic castration resistant prostate cancer (mCRPC): A phase 1b study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5053

N/A

0.524DataRank · unranked

32 citations

Srey Luch Sam, Vadim S. Koshkin, Eric J. Small, Felix Y. Feng, Ivan de Kouchkovsky +12 more

Chronologically modified androgen receptor in recurrent castration-resistant prostate cancer and its therapeutic targeting

Science Translational Medicine(2022)10.1126/scitranslmed.abg4132

N/A

0.489DataRank · unranked

25 citations

Kiran Mahajan, Arun Renganathan, Cody Weimholt, Jingqin Luo, Vandna Kukshal +11 more

Transcriptome profiling of NRG Oncology/RTOG 9601: Validation of a prognostic genomic classifier in salvage radiotherapy prostate cancer patients from a prospective randomized trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.276

Top 39%

0.489DataRank

Top 39%11 citations

Howard M. Sandler, Huei–Chung Huang, Jeffry Simko, Elai Davicioni, Paul L. Nguyen +15 more

Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium

The Lancet Oncology(2025)10.1016/s1470-2045(25)00034-8

N/A

0.457DataRank · unranked

20 citations

Yilun Sun, Alison Tree, Emma Hall, David P. Dearnaley, Charles Catton +29 more

Prostate-specific Membrane Antigen and Fluciclovine Transporter Genes are Associated with Variable Clinical Features and Molecular Subtypes of Primary Prostate Cancer

European Urology(2021)10.1016/j.eururo.2021.03.017

N/A

0.449DataRank · unranked

19 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Yang Liu, Jonathan Chou +17 more

High-Purity CTC RNA Sequencing Identifies Prostate Cancer Lineage Phenotypes Prognostic for Clinical Outcomes

Cancer Discovery(2025)10.1158/2159-8290.cd-24-1509

N/A

0.425DataRank · unranked

16 citations

Jamie M. Sperger, Amy K. Taylor, Katharine E. Tippins, Shannon R. Reese, V. Carreño +31 more

Identification of a Predictive Genomic Biomarker for Prostate-directed Therapy in Synchronous Low-volume Metastatic Castration-sensitive Prostate Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.07.014

N/A

0.385DataRank · unranked

12 citations

Amol C. Shetty, Yang Song, Theresa Hodges, Tung Hoang, Zaker Rana +11 more

Updated results of phase II trial using escalating doses of neoadjuvant atezolizumab for cisplatin-ineligible patients with nonmetastatic urothelial cancer (NCT02451423).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.e16510

N/A

0.269DataRank · unranked

5 citations

Li Zhang, David Y. Oh, Sima P. Porten, Maxwell V. Meng, Raj S. Pruthi +15 more

Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.009

N/A

0.214DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Jeffry Simko +17 more

Data from DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations

(2023)10.1158/0008-5472.c.6599642.v1

N/A

0.104DataRank · unranked

1 citations

Antonio Rodríguez-Calero, Andrej Benjak, Dilara Akhoundova, Sina Maletti, Ursula Amstutz +18 more

Integrative identification of non-coding regulatory regions driving metastatic prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.14.535921

N/A

0.104DataRank · unranked

1 citations

Ruhollah Moussavi-Baygi, Heather Karner, Mehran Karimzadeh, Kristle Garcia, Tanvi Joshi +8 more

The Mutational Landscape of Metastatic Castration-sensitive Prostate Cancer: The Spectrum Theory Revisited

European Urology(2021)10.1016/j.eururo.2020.12.040

N/A

0DataRank · unranked

100 citations

Kim Van der Eecken, Ryan Phillips, Neil R. Parikh, Pedro Isaacsson Velho, Tamara L. Lotan +19 more

Cell-free DNA concentration and fragment size as a biomarker for prostate cancer

Scientific Reports(2021)10.1038/s41598-021-84507-z

N/A

0DataRank · unranked

79 citations

Clinton L. Cario, Lancelote Leong, Karen López, César Márquez, Carissa Chu +14 more

Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance

Cancer Research(2021)10.1158/0008-5472.can-20-3845

N/A

0DataRank · unranked

79 citations

Mithila Sawant, Arun Renganathan, Kiran Mahajan, Eric H. Kim, Jingqin Luo +5 more

CRISPRi screens reveal a DNA methylation-mediated 3D genome dependent causal mechanism in prostate cancer

Nature Communications(2021)10.1038/s41467-021-21867-0

N/A

0DataRank · unranked

66 citations

Fraser Soares, Ji‐Han Xia, Yue Yang, Jing Li, Haiyang Guo +27 more

An Expert Review on the Combination of Relugolix With Definitive Radiation Therapy for Prostate Cancer

International Journal of Radiation Oncology*Biology*Physics(2021)10.1016/j.ijrobp.2021.12.005

N/A

0DataRank · unranked

12 citations

Nicholas G. Zaorsky, H.P. Bagshaw, Alejandro Berlín, Alison Tree, Sandra Turner +21 more

Cell-Free DNA Detection of Tumor Mutations in Heterogeneous, Localized Prostate Cancer Via Targeted, Multiregion Sequencing

JCO Precision Oncology(2021)10.1200/po.20.00428

N/A

0DataRank · unranked

11 citations

Clinton L. Cario, Lancelote Leong, Karen López, César Márquez, Patricia Li +14 more

Novel genomic signature predictive of response to immune checkpoint blockade: A pan-cancer analysis from project Genomics Evidence Neo-plasia Information Exchange (GENIE)

Cancer Genetics(2021)10.1016/j.cancergen.2021.08.004

N/A

0DataRank · unranked

3 citations

William L. Hwang, Jimmy A. Guo, Hannah I. Hoffman, Matthew C. Abramowitz, Ziad El-Bakouny +24 more

INNOVATE (NRG-GU008): A randomized phase III trial of salvage radiotherapy and androgen deprivation therapy (ADT) with/without abiraterone and apalutamide for patients with node-positive prostate cancer after radical prostatectomy.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps179

N/A

0DataRank · unranked

6 citations

Theodore Karrison, C.A. Lawton, William A. Hall, Hala T. Borno, Mihaela Roşu +8 more

Prospective randomized trial of gene expression classifier utility following radical prostatectomy (G-MINOR).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.15

N/A

0DataRank · unranked

6 citations

Linda A. Okoth, Daniel E. Spratt, Rodney L. Dunn, Felix Y. Feng, Anna Johnson +16 more

5-hydroxymethylcytosine as a liquid biopsy biomarker in mCRPC.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.148

N/A

0DataRank · unranked

3 citations

Shuang G. Zhao, Eric J. Small, Yuhong Ning, Corinne Maurice‐Dror, Adam Foye +15 more

Longitudinal predictive ability of mapping algorithms: Secondary analysis of NRG Oncology/RTOG 0415.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.60

N/A

0DataRank · unranked

0 citations

Howard M. Sandler, W. Robert Lee, Ester Villalonga Olives, C. Daniel Mullins, Deborah Watkins Bruner +15 more

CUB domain containing protein 1 (CDPC1) is a target for radioligand therapy in castration resistant prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.17.448569

N/A

0DataRank · unranked

0 citations

Kai Trepka, Yung-Hua Wang, Shalini Chopra, Nima Hooshdaran, Hyun‐Jung Kim +14 more

TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells

European Urology Oncology(2022)10.1016/j.euo.2021.11.005

N/A

0DataRank · unranked

87 citations

Kai Trepka, Martin Sjöström, Emily A. Egusa, Carissa Chu, Jun Zhu +14 more

The 5-Hydroxymethylcytosine Landscape of Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1123

N/A

0DataRank · unranked

67 citations

Shuang G. Zhao, Samuel Levy, Meng Zhang, Yuhong Ning, Raunak Shrestha +58 more

Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN)

European Urology(2022)10.1016/j.eururo.2022.07.011

N/A

0DataRank · unranked

63 citations

Fang‐I Chu, Howard M. Sandler, Felix Y. Feng, Jason A. Efstathiou, Christopher U. Jones +37 more

Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1433

N/A

0DataRank · unranked

61 citations

Emily A. Egusa, Sinan Wang, Michelle L. Badura, Fei Lee, Anil P. Bidkar +22 more

Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance

Nature Communications(2022)10.1038/s41467-022-34724-5

N/A

0DataRank · unranked

58 citations

Surbhi Chouhan, Kiran Mahajan, Arun Renganathan, Cody Weimholt, Shambhavi Bhagwat +10 more

Impact of radiopharmaceutical therapy (177Lu, 225Ac) microdistribution in a cancer-associated fibroblasts model

EJNMMI Physics(2022)10.1186/s40658-022-00497-5

N/A

0DataRank · unranked

15 citations

Stig Palm, Stephen A. Graves, Felix Y. Feng, Thomas A. Hope, Jonathan Tranel

CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null Disease

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3858

N/A

0DataRank · unranked

30 citations

Shalini Chopra, Kai Trepka, Yung-Hua Wang, Sasank Sakhamuri, Nima Hooshdaran +18 more

Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1

Oncogene(2022)10.1038/s41388-022-02179-z

N/A

0DataRank · unranked

17 citations

Veronica Steri, Hao G. Nguyen, Yeonjoo Hwang, John D. Gordan, Byron Hann +3 more

Selective vulnerabilities in the proteostasis network of castration-resistant prostate cancer

Cell chemical biology(2022)10.1016/j.chembiol.2022.01.008

N/A

0DataRank · unranked

13 citations

Isabelle R. Taylor, Frank Echtenkamp, Poornima Ramkumar, Mohamed Alshalalfa, Génesis M. Rivera-Márquez +8 more

Analysis of MRE11 and Mortality Among Adults With Muscle-Invasive Bladder Cancer Managed With Trimodality Therapy

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.42378

N/A

0DataRank · unranked

13 citations

Jennifer Moughan, David T. Miyamoto, Jeff Simko, William U. Shipley, Phillip J. Gray +20 more

PLX038: A Long-Acting Topoisomerase I Inhibitor With Robust Antitumor Activity in ATM -Deficient Tumors and Potent Synergy With PARP Inhibitors

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-22-0217

N/A

0DataRank · unranked

11 citations

Shaun D. Fontaine, Morgan E. Diolaiti, Parth Desai, Rajesh Kumar, Nobuyuki Takahashi +9 more

Genomic biomarkers to guide precision radiotherapy in prostate cancer

The Prostate(2022)10.1002/pros.24373

N/A

0DataRank · unranked

10 citations

Matthew P. Deek, Kim Van der Eecken, Alexander W. Wyatt, Amar U. Kishan, Jason K. Molitoris +11 more

The Influence of the Pretreatment Immune State on Response to Radiation Therapy in High-Risk Prostate Cancer: A Validation Study From NRG/RTOG 0521

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.05.048

N/A

0DataRank · unranked

4 citations

Theodore Karrison, Seth A. Rosenthal, Mahul B. Amin, Leonard G. Gomella, James A. Purdy +15 more

External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis

International Journal of Radiation Oncology*Biology*Physics(2022)10.1016/j.ijrobp.2022.09.075

N/A

0DataRank · unranked

5 citations

Ting Martin, J.K. Wong, Bradley J. Stish, Robert T. Dess, Avinash Pilar +36 more

Prostate cancer risk in African American men evaluated via digital histopathology multi-modal deep learning models developed on NRG Oncology phase III clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.108

N/A

0DataRank · unranked

6 citations

Jingbin Zhang, Andre Esteva, Osama Mohamad, Douwe van der Wal, Jeffry Simko +15 more

Candidate surrogate endpoints in advanced prostate cancer: Aggregate meta-analysis of 143 randomized trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.5039

N/A

0DataRank · unranked

0 citations

Ralph Jiang, E Jaworski, Krystal Morales, Robert T. Dess, Will Jackson +15 more

Fragmentomic analysis of circulating tumor DNA-targeted cancer panels

Annals of Oncology(2023)10.1016/j.annonc.2023.06.001

N/A

0DataRank · unranked

67 citations

Marina N. Sharifi, Jamie M. Sperger, Yue Shi, Matti Annala, Matthew L. Bootsma +29 more

Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation

Cancer Discovery(2023)10.1158/2159-8290.cd-23-0754

N/A

0DataRank · unranked

62 citations

Orsetta Quaini, Kei Mizuno, Francesco Orlando, Yari Ciani, Sheng-Yu Ku +23 more

Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer

Nature Communications(2023)10.1038/s41467-023-38887-7

N/A

0DataRank · unranked

42 citations

Dhivya Sridaran, Surbhi Chouhan, Cody Weimholt, Audrey Wilson, Jingqin Luo +9 more

Co-evolution of AR gene copy number and structural complexity in endocrine therapy resistant prostate cancer

NAR Cancer(2023)10.1093/narcan/zcad045

N/A

0DataRank · unranked

29 citations

Jeffrey T. Miller, Sarah A. Munro, Todd P. Knutson, Yingming Li, Courtney N. Passow +12 more

Transcriptomic and clinical heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer

Annals of Oncology(2023)10.1016/j.annonc.2023.04.515

N/A

0DataRank · unranked

28 citations

Amol C. Shetty, Alex Hakansson, Kim Van der Eecken, Yang Song, Y. Liu +27 more

Clinical and Genomic Differences Between Advanced Molecular Imaging-detected and Conventional Imaging-detected Metachronous Oligometastatic Castration-sensitive Prostate Cancer

European Urology(2023)10.1016/j.eururo.2023.04.025

N/A

0DataRank · unranked

25 citations

Yang Song, Kim Van der Eecken, Amol C. Shetty, Keara English, Theresa Hodges +24 more

DNA Methylation Landscapes of Prostate Cancer Brain Metastasis Are Shaped by Early Driver Genetic Alterations

Cancer Research(2023)10.1158/0008-5472.can-22-2236

N/A

0DataRank · unranked

24 citations

Antonio Rodríguez-Calero, Andrej Benjak, Dilara Akhoundova, Sina Maletti, Ursula Amstutz +18 more

Histology Specific Molecular Biomarkers: Ushering in a New Era of Precision Radiation Oncology

Seminars in Radiation Oncology(2023)10.1016/j.semradonc.2023.03.001

N/A

0DataRank · unranked

2 citations

Heath D. Skinner, Matthew E. Witek, Mark V. Mishra, Young Kwok, Elai Davicioni +6 more

NRG-GU012: Randomized phase II stereotactic ablative radiation therapy (SABR) for patients with metastatic unresected renal cell carcinoma (RCC) receiving immunotherapy (SAMURAI).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4604

N/A

0DataRank · unranked

21 citations

Theodore Karrison, Bradley A. McGregor, Pedro C. Barata, Himanshu Nagar, Chad Tang +10 more

Large tandem duplications in cancer result from transcription and DNA replication collisions

medRxiv(2023)10.1101/2023.05.17.23290140

N/A

0DataRank · unranked

4 citations

Michelle L. Badura, Patrick C. O’Leary, Henry M. Delavan, Troy M. Robinson, Emily A. Egusa +10 more

Basal-luminal subtyping of localized high-risk prostate cancer and benefit of adding docetaxel to definitive radiotherapy with androgen suppression in the NRG Oncology/RTOG 0521 phase III trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.5094

N/A

0DataRank · unranked

3 citations

James A. Proudfoot, Elai Davicioni, Yang Liu, Daniel E. Spratt, Felix Y. Feng +15 more

Prognostic impact of circulating tumor cells in oligometastatic hormone-sensitive prostate cancer following metastasis-directed therapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.199

N/A

0DataRank · unranked

1 citations

Philip Sutera, Ryan Phillips, Mathew Pierre Deek, Noura Radwan, Catherine H. Marshall +15 more

Determining the impact of genomic classifier testing on patient-reported quality of life after prostatectomy: Results from the G-MINOR randomized trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.345

N/A

0DataRank · unranked

0 citations

Stephanie Daignault‐Newton, Rodney Dunn, Daniel E. Spratt, Linda A. Okoth, Felix Y. Feng +15 more

Data from Loss of Long Noncoding RNA NXTAR in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide Resistance

(2023)10.1158/0008-5472.c.6513456.v1

N/A

0DataRank · unranked

0 citations

Mithila Sawant, Arun Renganathan, Kiran Mahajan, Eric H. Kim, Jingqin Luo +5 more

Data from Resistance to ATR Inhibitors Is Mediated by Loss of the Nonsense-Mediated Decay Factor UPF2

(2023)10.1158/0008-5472.c.6513989

N/A

0DataRank · unranked

0 citations

Huadong Chen, Yagmur U. Doruk, Tess Williamson, Benjamin J. Polacco, Andrew S. McNeal +13 more

Data from Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

(2023)10.1158/1078-0432.c.6530730

N/A

0DataRank · unranked

0 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Data from Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

(2023)10.1158/1078-0432.c.6529904

N/A

0DataRank · unranked

0 citations

Jun Li, Jun Hua, Yang Su, Denis Beckford-Vera, Walter Zhao +20 more

ZNF397 Loss Triggers TET2-driven Epigenetic Rewiring, Lineage Plasticity, and AR-targeted Therapy Resistance in AR-dependent Cancers

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.24.563645

N/A

0DataRank · unranked

0 citations

Zhaoning Wang, Martin Sjöström, Su Deng, Choushi Wang, Nickolas A. Johnson +22 more

Androgen Receptor Inhibition Increases MHC Class I Expression and Improves Immune Response in Prostate Cancer

Cancer Discovery(2024)10.1158/2159-8290.cd-24-0559

N/A

0DataRank · unranked

46 citations

Fanny Polesso, Julie N. Graff, Jessica E. Hawley, Alexis K. Smith, Arian Lundberg +35 more

Integrated analyses highlight interactions between the three-dimensional genome and DNA, RNA and epigenomic alterations in metastatic prostate cancer

Nature Genetics(2024)10.1038/s41588-024-01826-3

N/A

0DataRank · unranked

38 citations

Matthew L. Bootsma, Stanley Zhou, Raunak Shrestha, Thaidy Moreno-Rodriguez, Arian Lundberg +41 more

Evaluating Immune Checkpoint Blockade in Metastatic Castration-Resistant Prostate Cancers with Deleterious CDK12 Alterations in the Phase 2 IMPACT Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0400

N/A

0DataRank · unranked

34 citations

Melissa A. Reimers, Chamila Perera, Wassim Abida, Jonathan Chou, Felix Y. Feng +17 more

An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression

Cancer Research(2024)10.1158/0008-5472.can-24-0890

N/A

0DataRank · unranked

27 citations

Lisa N. Chesner, Meng Zhang, Stanley Zhou, Adam Foye, Arian Lundberg +13 more

Validation of an artificial intelligence-based prognostic biomarker in patients with oligometastatic Castration-Sensitive prostate cancer

Radiotherapy and Oncology(2024)10.1016/j.radonc.2024.110618

N/A

0DataRank · unranked

22 citations

Matthew P. Deek, Adrianna A. Mendes, Yang Song, Amol C. Shetty, Soha Bazyar +24 more

Integrative analysis of ultra-deep RNA-seq reveals alternative promoter usage as a mechanism of activating oncogenic programmes during prostate cancer progression

Nature Cell Biology(2024)10.1038/s41556-024-01438-3

N/A

0DataRank · unranked

18 citations

Martin Sjöström, Xiekui Cui, Adam Foye, Kyle Kai‐How Farh, Raunak Shrestha +12 more

Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials

European Urology(2024)10.1016/j.eururo.2024.06.019

N/A

0DataRank · unranked

12 citations

Vinnie Y.T. Liu, Angela Y. Jia, Trevor J. Royce, Howard M. Sandler, Stephanie L. Pugh +3 more

Transcription and DNA replication collisions lead to large tandem duplications and expose targetable therapeutic vulnerabilities in cancer

Nature Cancer(2024)10.1038/s43018-024-00848-4

N/A

0DataRank · unranked

12 citations

Michelle L. Badura, Patrick C. O’Leary, Henry M. Delavan, Troy M. Robinson, Emily A. Egusa +10 more

Single cell-transcriptomic analysis informs the lncRNA landscape in metastatic castration resistant prostate cancer

npj Genomic Medicine(2024)10.1038/s41525-024-00401-3

N/A

0DataRank · unranked

10 citations

Ha X. Dang, Meng Zhang, David A. Quigley, Felix Y. Feng, Christopher A. Maher +1 more

Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial

European Urology(2024)10.1016/j.eururo.2024.09.011

N/A

0DataRank · unranked

8 citations

Stephanie Daignault‐Newton, Daniel E. Spratt, R. Dunn, Udit Singhal, Linda A. Okoth +19 more

Prostate-Specific Membrane Antigen PET Response Associates with Metastasis-Free Survival After Stereotactic Ablative Radiation in Oligometastatic Prostate Cancer

Advances in Radiation Oncology(2024)10.1016/j.adro.2024.101507

N/A

0DataRank · unranked

7 citations

Matthew P. Deek, Rebecca A. Deek, Ozan Cem Güler, Pervin Hürmüz, Mehmet Reyhan +22 more

Expert Perspectives on Controversies in Castration-Sensitive Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 1

JU Open Plus(2024)10.1097/ju9.0000000000000137

N/A

0DataRank · unranked

7 citations

Alan H. Bryce, Maha Hussain, Neeraj Agarwal, Himisha Beltran, Matthew R. Cooperberg +33 more

Integrative identification of non-coding regulatory regions driving metastatic prostate cancer

Cell Reports(2024)10.1016/j.celrep.2024.114764

N/A

0DataRank · unranked

4 citations

Ruhollah Moussavi-Baygi, Heather Karner, Mehran Karimzadeh, Hassan Yousefi, Sean M. Lee +10 more

Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2

JU Open Plus(2024)10.1097/ju9.0000000000000138

N/A

0DataRank · unranked

3 citations

E. David Crawford, Neeraj Agarwal, Maha Hussain, Himisha Beltran, Matthew R. Cooperberg +33 more

Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTOG 0712

European Urology Oncology(2024)10.1016/j.euo.2024.03.015

N/A

0DataRank · unranked

2 citations

Sophia C. Kamran, Amol C. Shetty, Philip Sutera, Yang Song, Soha Bazyar +29 more

Technical note: Errors introduced when using Dose Voxel Kernels for estimating absorbed dose from radiopharmaceutical therapies involving alpha emitters

Medical Physics(2024)10.1002/mp.16970

N/A

0DataRank · unranked

2 citations

Stig Palm, Felix Y. Feng, Sara St. James, Thomas A. Hope, Jonathan Tranel

Tumor transcriptome-wide expression classifiers predict treatment sensitivity in advanced prostate cancers

Cell(2025)10.1016/j.cell.2025.07.042

N/A

0DataRank · unranked

24 citations

Peter Dutey‐Magni, Marina Parry, Larissa Mendes, Ashwin Sachdeva, James A. Proudfoot +42 more

Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer

Nature Communications(2025)10.1038/s41467-025-62710-0

N/A

0DataRank · unranked

8 citations

Henry M. Delavan, Elizabeth Yip, Corynn Kasap, Jun Zhu, Roshan Lodha +21 more

Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panels

Nature Communications(2025)10.1038/s41467-025-64153-z

N/A

0DataRank · unranked

8 citations

Marina N. Sharifi, Jamie M. Sperger, Matthew R. Chrostek, Matthew L. Bootsma, Shannon R. Reese +22 more

Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer

Nature Genetics(2025)10.1038/s41588-025-02388-8

N/A

0DataRank · unranked

6 citations

James E. Melnyk, Becky Xu Hua Fu, Raunak Shrestha, Meng Zhang, Martin Sjöström +34 more

PROX1 is an early driver of lineage plasticity in prostate cancer

Journal of Clinical Investigation(2025)10.1172/jci187490

N/A

0DataRank · unranked

9 citations

Mingchen Shi, Anbarasu Kumaraswamy, Dong Lin, Dhruv Khokhani, Yong Wang +41 more

Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity

Nature Communications(2025)10.1038/s41467-025-60745-x

N/A

0DataRank · unranked

4 citations

Meng Zhang, Tatyanah Farsh, Haolong Li, Audrey Kishishita, Abhilash Barpanda +22 more

Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancer

npj Precision Oncology(2025)10.1038/s41698-025-01002-8

N/A

0DataRank · unranked

1 citations

Ya‐Mei Hu, Joel A. Yates, Chao Zhang, Eva S. Rodansky, Dhruv Khokhani +26 more

Decipher score as a predictor of response to treatment intensification in the NRG Oncology-RTOG 0534 (SPPORT) phase III randomized post-prostatectomy salvage radiotherapy trial.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.5_suppl.399

N/A

0DataRank · unranked

3 citations

Marla Johnson, J. Proudfoot, Elai Davicioni, Alan Dal Pra, Jeff Simko +15 more

Diverse AR Gene Rearrangements Mediate Resistance to Androgen Receptor Inhibitors in Metastatic Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-3023

N/A

0DataRank · unranked

86 citations

Rendong Yang, Christine Henzler, Yeung Ho, Courtney N. Passow, Benjamin Auch +14 more

Autoantibody Landscape in Patients with Advanced Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1966

N/A

0DataRank · unranked

20 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +26 more

Tumor Immune Microenvironment Clusters in Localized Prostate Adenocarcinoma: Prognostic Impact of Macrophage Enriched/Plasma Cell Non-Enriched Subtypes

Journal of Clinical Medicine(2020)10.3390/jcm9061973

N/A

0DataRank · unranked

21 citations

Mark Farha, Sudharsan Srinivasan, Ruple Jairath, Michael D. Green, Robert T. Dess +8 more

Genomic and clinical characterization of stromal infiltration markers in prostate cancer

Cancer(2020)10.1002/cncr.32688

N/A

0DataRank · unranked

14 citations

Mohammed Alshalalfa, Shuang G. Zhao, Himisha Beltran, William S. Chen, Fallon Chipidza +11 more

Diversity in Androgen Receptor Action Among Treatment-naïve Prostate Cancers Is Reflected in Treatment Response Predictions and Molecular Subtypes

European Urology Open Science(2020)10.1016/j.euros.2020.10.002

N/A

0DataRank · unranked

11 citations

Qiang Hu, Yang Liu, Mohammed Alshalalfa, Xin Zhao, Irène Wang +12 more

Copy Number Loss of 17q22 Is Associated with Enzalutamide Resistance and Poor Prognosis in Metastatic Castration-Resistant Prostate Cancer

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2303

N/A

0DataRank · unranked

13 citations

Duanchen Sun, Eric Lu, Joshua A. Urrutia, Robert E. Reiter, Matthew B. Rettig +17 more

Molecular Imaging of Prostate Cancer Targeting CD46 Using ImmunoPET

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3310

N/A

0DataRank · unranked

41 citations

Jun Li, Jun Hua, Su Yang, Denis Beckford-Vera, Walter Zhao +20 more

Performance of clinicopathologic models in men with high risk localized prostate cancer: impact of a 22-gene genomic classifier

Prostate Cancer and Prostatic Diseases(2020)10.1038/s41391-020-0226-2

N/A

0DataRank · unranked

26 citations

Samuel R. Birer, R. Jeffrey Karnes, Jingbin Zhang, Elai Davicioni, Eric A. Klein +22 more

Role of Specialized Composition of SWI/SNF Complexes in Prostate Cancer Lineage Plasticity

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.06.949131

N/A

0DataRank · unranked

27 citations

Anke Augspach, Maria Rosaria De Filippo, Davide Prandi, Phillip Thienger, Matteo Benelli +25 more

Luminal B subtype as a predictive biomarker of docetaxel benefit for newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC): A correlative study of E3805 CHAARTED.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.162

N/A

0DataRank · unranked

18 citations

Victoria Wang, Yu‐Hui Chen, Felix Y. Feng, Robert B. Den, Gerhardt Attard +10 more

Adjuvant docetaxel for high-risk localized prostate cancer: Update of NRG Oncology/RTOG 0521.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.333

N/A

0DataRank · unranked

11 citations

Theodore Karrison, Oliver Sartor, Leonard G. Gomella, Mahul B. Amin, James A. Purdy +15 more

Differential expression of PSMA and 18F-fluciclovine transporter genes in metastatic castrate-resistant and treatment-emergent small cell/neuroendocrine prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.24

N/A

0DataRank · unranked

5 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +14 more

Characterization of PSMA and 18F-fluciclovine transporter gene expression in localized prostate cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.295

N/A

0DataRank · unranked

0 citations

Mohammed Alshalalfa, Martin Sjöström, Shuang G. Zhao, Annika Herlemann, Jonathan Chou +15 more

Autoantibody landscape of advanced prostate cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.02.074575

N/A

0DataRank · unranked

0 citations

Winston Haynes, Rebecca Waitz, Kathy Kamath, Agustin Vega-Crespo, Raunak Shrestha +25 more

Cell-free DNA as a biomarker for prostate cancer: elevated concentration and decreased fragment size

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.26.215020

N/A

0DataRank · unranked

0 citations

Clinton L. Cario, Lancelote Leong, Karen López, César Márquez, Carissa Chu +14 more

Heterogeneity in NECTIN4 Expression Across Molecular Subtypes of Urothelial Cancer Mediates Sensitivity to Enfortumab Vedotin

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4175

N/A

0DataRank · unranked

156 citations

Martin Sjöström, Emily A. Egusa, Ewan A. Gibb, Michelle L. Badura, Jun Zhu +11 more

Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis

The Lancet Oncology(2021)10.1016/s1470-2045(20)30730-0

N/A

0DataRank · unranked

112 citations

Ralph Jiang, David G. Wallington, Gavin Jones, Samuel R. Birer, Neil Jairath +20 more

Felix Y. Feng

Indexed papers

Top data-sharing exemplar

Papers